Sleep Apnea Therapy Device
Project Overview
Sleep Apnea is a sleep disorder which currently prevents more than 20 million Americans from reaching “deep” sleep. Sleep apnea has been known to increase the risk of heart issues, high blood pressure, stroke, and other diseases. Current Sleep Apnea treatments, such as Continuous Positive Airway Pressure (CPAP) devices, are rejected by nearly 50% of individuals who have used them because they are loud, uncomfortable, and may cause nasal congestion and dryness. Our team firmly believes that these side effects should not be ignored and therefore proposes a device which may reduce them. This alternative device incorporates “Smart CO2” which was developed in the lab of our client, Dr. John Webster. The “Smart CO2” system has been proven to reduce the occurrence of apneas and shows great potential as a long-term alternative to CPAP. “Smart CO2” elevates the amount of CO2 in the lungs by increasing dead space, effectively inducing mild hypercapnia which has been proven to improve ventilatory stimulation and the symptoms Central Sleep Apnea (CSA) may cause.
Team Picture
Images
Files
- PDS (September 23, 2016)
- Design Matrix (December 14, 2016)
- Preliminary Presentation (October 19, 2016)
- Preliminary Report (October 19, 2016)
- Sleep Apnea Therapy Device Poster (December 14, 2016)
- Final Report (December 14, 2016)
Contact Information
Team Members
- William Guns - Team Leader
- Tanya Iskandar - Communicator
- John Riley - BSAC
- Calvin Hedberg - BWIG
- Aman Nihal - BPAG
Advisor and Client
- Dr. Jeremy Rogers - Advisor
- Prof. John Webster - Client
Related Projects
- Spring 2017: Sleep apnea therapy device
- Fall 2016: Sleep Apnea Therapy Device
- Fall 2014: CO2 prevents sleep apnea
- Fall 2013: CO2 prevents sleep apnea